Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17551066.
- Also identified by PMC identifier 2600047.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Barrett's oesophagus is premalignant. Oesophagectomy is traditionally regarded as the standard treatment option in the presence of high grade intraepithelial neoplasia or intramucosal cancer. However, oesophagectomy is associated with high rates of mortality and morbidity. Endoscopic ablative therapies are limited by the lack of tissue for histological assessment, and the ablation may be incomplete. Endoscopic mucosal resection is an alternative to surgery in the management of high grade intraepithelial neoplasia and intramucosal cancer. It is less invasive than surgery and, unlike ablative treatments, provides tissue for histological assessment. This review will cover the indications, techniques and results of endoscopic mucosal resection.
Medical subject headings
- Barrett Esophagus
- Endoscopy, Gastrointestinal
- Esophageal Neoplasms
- Esophagectomy
- Precancerous Conditions